5Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP conference on antithrombotic and thrombolytic therapy[J]. Chest, 2004, 126 (3 Suppl):338S-400S.
6Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J]. Chest, 2008, 133(6 Suppl):381S-453S.
7Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl):e195S-e226S.
8Hostler DC, Marx ES, Moores LK, et al. Validation of the IMPROVE bleeding risk score[J]. Chest, 2015.
9Persson G, StrSmberg J, Svennblad B, et al. Risk of bleeding associated with use of systemic thromboembolic prophylaxis during laparoscopic cholecystectomy[J]. Br J Surg, 2012, 99(7): 979-986.
10Linkins LA, Dans AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].Chest, 2012, 141(2 Suppl):e495S-e530S.
